Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomics, |
RCV002208775 | SCV002495943 | uncertain significance | Normophosphatemic familial tumoral calcinosis; MIRAGE syndrome | 2021-06-22 | criteria provided, single submitter | clinical testing | SAMD9 NM_017654.3 exon 3 p.Leu987Ser (c.2960T>C): This variant has not been reported in the literature but is present in 0.006% (1/15270) of Latino alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/7-93103138-A-G?dataset=gnomad_r3). Evolutionary conservation suggests that this variant may not impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV004548239 | SCV004110075 | uncertain significance | SAMD9-related disorder | 2023-07-29 | criteria provided, single submitter | clinical testing | The SAMD9 c.2960T>C variant is predicted to result in the amino acid substitution p.Leu987Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-92732451-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |